U.S. Serums and Vaccines Manufacturers Companies
Featured companies
Not satisfied? Select a reason•Rate this page•Send feedback
Or try our search form or quick navigation by category and location
Atlas Biologicals, Inc is one of the only companies in the United States that manufactures and produces Fetal Bovine Serum as its primary product.
New England Serum Co
Beverly MA 01915
Whereorg has 42 results under Serums and Vaccines Manufacturers Companies in the United States.
Narrow down the browsing criteria below to see more companies.
Other categories
All industries
Chemical Materials Biological Products, Except Diagnostic Substances Serums and Vaccines Manufacturers
Select a location for category Serums and Vaccines Manufacturers
Quick navigation
All industries
Chemical Materials
Biological Products, Except Diagnostic Substances
Serums and Vaccines Manufacturers
Subcategory
- Agar Culture Media8
- Allergens, Allergenic Extracts16
- Antitoxins2
- Bacterial Vaccines739
- Bacteriological Media15
- Biological Products Manufacturers1709
- Biological Specimens Manufacturers745
- Blood Derivatives25
- Coagulation Products11
- Culture Media314
- Extracts57
- Plasmas264
- Toxins9
- Toxins, Viruses, and Similar Substances, Including Venom6
- Vaccines129
- Vaccines and Other Immunizing Products66
- Venoms75
- Veterinary Biological Products68
- Viruses6
All states
Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020